NRC-IRAP Is On A Roll: 7 Bio Investments in 7 Weeks

NRC-IRAP,* which got $170 million in Canadian stimulus money, has been deploying funds quite rapidly and has included a significant number of biotechs in its largesse.  I found these from July and August:

• a $260,000 grant to ImmunoVaccine Technologies Inc.;
• a $498,500 grant to Opsens Inc. (TSX-V: OPS);
• an undisclosed amount to Paladin Labs (TSE: PLB);
• a $374,500 grant to MedSenses;
• a $345,000 grant to Timeless Technologies Inc.;
• Chemaphor (TSX-V: CFR), after its breakup with Lilly, gets $296,386; and, last but by no means least…
• a $1,950,000 contribution to Genesis Genomics Inc.

Am I missing others?  Let us know in the comments.

Oh, and speaking of government money, hopefully you’ve started following the Twitter stream @crossborderbio and you saw this announcement earlier today about EDC and Brookfield’s $1 billion fund for DIP lending.

* National Research Council of Canada Industrial Research Assistance Program.  Stick to the abbreviation.